<code id='389198C191'></code><style id='389198C191'></style>
    • <acronym id='389198C191'></acronym>
      <center id='389198C191'><center id='389198C191'><tfoot id='389198C191'></tfoot></center><abbr id='389198C191'><dir id='389198C191'><tfoot id='389198C191'></tfoot><noframes id='389198C191'>

    • <optgroup id='389198C191'><strike id='389198C191'><sup id='389198C191'></sup></strike><code id='389198C191'></code></optgroup>
        1. <b id='389198C191'><label id='389198C191'><select id='389198C191'><dt id='389198C191'><span id='389198C191'></span></dt></select></label></b><u id='389198C191'></u>
          <i id='389198C191'><strike id='389198C191'><tt id='389198C191'><pre id='389198C191'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:5259
          A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat
          PATRICK T. FALLON/AFP via Getty Images

          You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

          Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

          advertisement

          He had a point.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk
          Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Researchers separate signal from noise in heart wearable data

          AdobeAswearablehealthdevicesgrowmorepopularintheU.S.,there’sagrowingopportunitytotrackthebroaderadul